|
Name |
O-Decylhydroxylamine
|
Molecular Formula | C10H23NO | |
IUPAC Name* |
O-decylhydroxylamine
|
|
SMILES |
CCCCCCCCCCON
|
|
InChI |
InChI=1S/C10H23NO/c1-2-3-4-5-6-7-8-9-10-12-11/h2-11H2,1H3
|
|
InChIKey |
MQNAOOIFODUDES-UHFFFAOYSA-N
|
|
Synonyms |
O-DECYLHYDROXYLAMINE; Hydroxylamine, O-decyl-; 29812-79-1; decyloxyamine; O-decyl-hydroxylamine; SCHEMBL6725430; DTXSID6074704; ZINC2011426; MFCD21920915; AKOS017981930; SY281732; EN300-1851870; A1-51525; Q63409742
|
|
CAS | 29812-79-1 | |
PubChem CID | 34704 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 173.3 | ALogp: | 4.4 |
HBD: | 1 | HBA: | 2 |
Rotatable Bonds: | 9 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 35.2 | Aromatic Rings: | 0 |
Heavy Atoms: | 12 | QED Weighted: | 0.425 |
Caco-2 Permeability: | -4.489 | MDCK Permeability: | 0.00003250 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.113 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.021 |
30% Bioavailability (F30%): | 0.133 |
Blood-Brain-Barrier Penetration (BBB): | 0.959 | Plasma Protein Binding (PPB): | 78.57% |
Volume Distribution (VD): | 1.188 | Fu: | 24.39% |
CYP1A2-inhibitor: | 0.943 | CYP1A2-substrate: | 0.517 |
CYP2C19-inhibitor: | 0.576 | CYP2C19-substrate: | 0.263 |
CYP2C9-inhibitor: | 0.324 | CYP2C9-substrate: | 0.881 |
CYP2D6-inhibitor: | 0.008 | CYP2D6-substrate: | 0.294 |
CYP3A4-inhibitor: | 0.052 | CYP3A4-substrate: | 0.07 |
Clearance (CL): | 8.67 | Half-life (T1/2): | 0.262 |
hERG Blockers: | 0.164 | Human Hepatotoxicity (H-HT): | 0.097 |
Drug-inuced Liver Injury (DILI): | 0.185 | AMES Toxicity: | 0.023 |
Rat Oral Acute Toxicity: | 0.422 | Maximum Recommended Daily Dose: | 0.033 |
Skin Sensitization: | 0.87 | Carcinogencity: | 0.231 |
Eye Corrosion: | 0.988 | Eye Irritation: | 0.988 |
Respiratory Toxicity: | 0.918 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000502 | 0.667 | D05ATI | 0.558 | ||||
ENC000473 | 0.667 | D0Z5SM | 0.492 | ||||
ENC000272 | 0.619 | D0Y8DP | 0.415 | ||||
ENC000274 | 0.619 | D07ILQ | 0.382 | ||||
ENC000275 | 0.619 | D0AY9Q | 0.382 | ||||
ENC000273 | 0.619 | D0O1PH | 0.370 | ||||
ENC000494 | 0.617 | D05QNO | 0.367 | ||||
ENC000854 | 0.614 | D00FGR | 0.363 | ||||
ENC000490 | 0.591 | D03ZJE | 0.348 | ||||
ENC000556 | 0.591 | D0XN8C | 0.348 |